chr4-94226402-C-T
Variant names:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_020159.5(SMARCAD1):c.368+106C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.034 ( 24 hom., cov: 18)
Exomes 𝑓: 0.038 ( 2 hom. )
Failed GnomAD Quality Control
Consequence
SMARCAD1
NM_020159.5 intron
NM_020159.5 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -1.31
Genes affected
SMARCAD1 (HGNC:18398): (SWI/SNF-related, matrix-associated actin-dependent regulator of chromatin, subfamily a, containing DEAD/H box 1) This gene encodes a member of the SNF subfamily of helicase proteins. The encoded protein plays a critical role in the restoration of heterochromatin organization and propagation of epigenetic patterns following DNA replication by mediating histone H3/H4 deacetylation. Mutations in this gene are associated with adermatoglyphia. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene. [provided by RefSeq, Dec 2011]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.92).
BP6
Variant 4-94226402-C-T is Benign according to our data. Variant chr4-94226402-C-T is described in ClinVar as [Benign]. Clinvar id is 1253074.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.0345 (4217/122306) while in subpopulation AFR AF= 0.0481 (1548/32156). AF 95% confidence interval is 0.0461. There are 24 homozygotes in gnomad4. There are 2056 alleles in male gnomad4 subpopulation. Median coverage is 18. This position pass quality control queck.
BS2
High AC in GnomAd4 at 4217 AD gene.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0344 AC: 4208AN: 122304Hom.: 23 Cov.: 18
GnomAD3 genomes
AF:
AC:
4208
AN:
122304
Hom.:
Cov.:
18
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome Data not reliable, filtered out with message: AS_VQSR AF: 0.0382 AC: 12673AN: 331916Hom.: 2 AF XY: 0.0388 AC XY: 6898AN XY: 177740
GnomAD4 exome
Data not reliable, filtered out with message: AS_VQSR
AF:
AC:
12673
AN:
331916
Hom.:
AF XY:
AC XY:
6898
AN XY:
177740
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0345 AC: 4217AN: 122306Hom.: 24 Cov.: 18 AF XY: 0.0359 AC XY: 2056AN XY: 57296
GnomAD4 genome
AF:
AC:
4217
AN:
122306
Hom.:
Cov.:
18
AF XY:
AC XY:
2056
AN XY:
57296
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Jun 19, 2021
GeneDx
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing
- -
-
Breakthrough Genomics, Breakthrough Genomics
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: not provided
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at